[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604130":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":29,"centralContacts":35,"locations":45,"responsibleParty":176,"collaborators":29,"id":178,"slug":179,"hasResults":180,"nctId":181,"briefTitle":182,"officialTitle":183,"acronym":184,"eligibilityCriteria":185,"healthyVolunteers":180,"sex":186,"minAge":187,"maxAge":29,"enrollmentInfo":188,"targetDuration":29,"studyType":191,"phases":192,"briefSummary":194,"conditions":195,"keywords":29,"overallStatus":48,"whyStopped":29,"lastUpdateSubmitDate":197,"lastUpdatePostDateStruct":198,"startDateStruct":201,"completionDateStruct":203,"leadSponsor":205,"locationsCount":206},{"fullName":5,"class":6},"TransMedics","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Part A (OCS Heart)","EXPERIMENTAL","DCD Donor Hearts \\& DBD Donor Hearts Initially Deemed Unsuitable for Cold Storage (Current Approved Indications)",[13],"Device: OCS Heart",{"label":15,"type":10,"description":16,"interventionNames":17},"Part B (OCS Heart)","DBD Donor Hearts Currently Used with Cold Storage",[13],{"label":19,"type":20,"description":16,"interventionNames":21},"Part B (SCS)","ACTIVE_COMPARATOR",[22],"Other: Static Cold Storage (SCS)",[24,30],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":29},"DEVICE","OCS Heart","Preservation of donor hearts with OCS Heart System and novel OCS Solution and OCS Functional Enhancer.",[9,15],null,{"type":31,"name":32,"description":33,"armGroupLabels":34,"otherNames":29},"OTHER","Static Cold Storage (SCS)","Preservation of donor hearts with static cold storage.",[19],[36,41],{"name":37,"role":38,"phone":39,"phoneExt":29,"email":40},"Raicca Haqqi","CONTACT","978-809-0620","rhaqqi@transmedics.com",{"name":42,"role":38,"phone":43,"phoneExt":29,"email":44},"Kausar Qidwai","978-494-7105","kqidwai@transmedics.com",[46,67,84,100,115,128,144,161],{"facility":47,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"University of California San Francisco","RECRUITING","San Francisco","California","94143","United States","US",{"type":55,"coordinates":56},"Point",[57,58],-122.41942,37.77493,{"lat":58,"lon":57},[61,64],{"name":62,"role":38,"phone":29,"phoneExt":29,"email":63},"Imani Dunn","Imani.Robinson@ucsf.edu",{"name":65,"role":66,"phone":29,"phoneExt":29,"email":29},"Liviu Klein, MD","PRINCIPAL_INVESTIGATOR",{"facility":68,"status":48,"city":69,"state":70,"zip":71,"country":52,"countryCode":53,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"Tampa General Hospital","Tampa","Florida","33606",{"type":55,"coordinates":73},[74,75],-82.45843,27.94752,{"lat":75,"lon":74},[78,82],{"name":79,"role":38,"phone":80,"phoneExt":29,"email":81},"Courtney Nicholas","813-844-4914","courtneynicholas@tgh.org",{"name":83,"role":66,"phone":29,"phoneExt":29,"email":29},"Lucian Lozonschi, MD",{"facility":85,"status":48,"city":86,"state":87,"zip":88,"country":52,"countryCode":53,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"Massachusetts General Hospital","Boston","Massachusetts","02114",{"type":55,"coordinates":90},[91,92],-71.05977,42.35843,{"lat":92,"lon":91},[95,98],{"name":96,"role":38,"phone":29,"phoneExt":29,"email":97},"Kamila Drezek","KDREZEK@mgh.harvard.edu",{"name":99,"role":66,"phone":29,"phoneExt":29,"email":29},"David D'Alessandro, MD",{"facility":101,"status":48,"city":102,"state":102,"zip":103,"country":52,"countryCode":53,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"Mount Sinai","New York","10029",{"type":55,"coordinates":105},[106,107],-74.00597,40.71427,{"lat":107,"lon":106},[110,113],{"name":111,"role":38,"phone":29,"phoneExt":29,"email":112},"Favio Herbas","Favio.Herbas@mountsinai.org",{"name":114,"role":66,"phone":29,"phoneExt":29,"email":29},"Anelechi Anyanwu, MD",{"facility":116,"status":117,"city":102,"state":102,"zip":118,"country":52,"countryCode":53,"cosmosGeoPoint":119,"geoPoint":121,"contacts":122},"Columbia University Irving Medical Center\u002F New York Presbyterian Hospital","NOT_YET_RECRUITING","10032",{"type":55,"coordinates":120},[106,107],{"lat":107,"lon":106},[123,126],{"name":124,"role":38,"phone":29,"phoneExt":29,"email":125},"Bo Lu","bl2699@cumc.columbia.edu",{"name":127,"role":66,"phone":29,"phoneExt":29,"email":29},"Koji Takeda, MD",{"facility":129,"status":48,"city":130,"state":102,"zip":131,"country":52,"countryCode":53,"cosmosGeoPoint":132,"geoPoint":136,"contacts":137},"Westchester Medical Center","Valhalla","10595",{"type":55,"coordinates":133},[134,135],-73.77513,41.07482,{"lat":135,"lon":134},[138,142],{"name":139,"role":38,"phone":140,"phoneExt":29,"email":141},"Corazon De La Pena","914-493-2483","Corazon.Delapena@wmchealth.org",{"name":143,"role":66,"phone":29,"phoneExt":29,"email":29},"David Spielvogel, MD",{"facility":145,"status":48,"city":146,"state":147,"zip":148,"country":52,"countryCode":53,"cosmosGeoPoint":149,"geoPoint":153,"contacts":154},"Duke University","Durham","North Carolina","27710",{"type":55,"coordinates":150},[151,152],-78.89862,35.99403,{"lat":152,"lon":151},[155,159],{"name":156,"role":38,"phone":157,"phoneExt":29,"email":158},"Sarah Casalinova","919-613-5621","sarah.casalinova@duke.edu",{"name":160,"role":66,"phone":29,"phoneExt":29,"email":29},"Jacob Schroder, MD",{"facility":162,"status":48,"city":163,"state":164,"zip":165,"country":52,"countryCode":53,"cosmosGeoPoint":166,"geoPoint":170,"contacts":171},"Baylor Scott and White","Dallas","Texas","75226",{"type":55,"coordinates":167},[168,169],-96.80667,32.78306,{"lat":169,"lon":168},[172,174],{"name":173,"role":38,"phone":29,"phoneExt":29,"email":29},"Lesia Parker",{"name":175,"role":66,"phone":29,"phoneExt":29,"email":29},"Dan Meyer, MD",{"type":177,"investigatorFullName":29,"investigatorTitle":29,"investigatorAffiliation":29,"oldNameTitle":29,"oldOrganization":29},"SPONSOR","100604130","enhancing-heart-allograft-function-with-the-ocs-heart-system-trial-100604130",false,"NCT07145515","Enhancing Heart Allograft Function With the OCS Heart System Trial","Enhancing Heart Allograft Function With the OCS Heart System (ENHANCE) Trial","ENHANCE","Part A - DCD Donor Hearts \\& DBD Donor Hearts Initially Deemed Unsuitable for Cold Storage (Current Approved Indications):\n\nDonor Inclusion Criteria\n\n* Donor hearts are deemed clinically acceptable for transplantation after physical examination of the donor hearts in the donor chest and\u002For on the back table in the donor operating room.\n* All DCD donors eligible for functional warm ischemic time criteria ≤ 30 minutes. WIT defined as time from when mean systolic blood pressure (SBP) is \\\u003C50mmHg (sustained for at least 5 minutes) to aortic cross clamp and administration of old cardioplegia in the donor.\n* DBD donor hearts with an expected cross clamp of ≥ 4 hours\n* DBD donor hearts with any of the following organ quality concerns, regardless of cross clamp time:\n\n  * Donor age ≥ 40 years old\n  * Unknown downtime\n  * Insignificant CAD\n  * LVEF ≤ 50%\n\nDonor Exclusion • Moderate to severe aortic incompetence\n\nPart B - DBD Donor Hearts Currently Used with Cold Storage (New Indication):\n\nDonor Inclusion Criteria\n\n* Donor hearts are deemed clinically acceptable for transplantation after physical examination of the donor hearts in the donor chest and\u002For on the back table in the donor operating room.\n* Eligible for randomization to OCS or SCS treatment arms.\n* DBD donor hearts with an expected cross clamp time of \\\u003C 4 hours.\n\nDonor Exclusion\n\n* Moderate to severe aortic incompetence\n* DBD donor with any of the following organ quality concerns:\n\n  * Donor age ≥ 40 years old\n  * Unknown downtime\n  * Insignificant CAD\n  * LVEF ≤ 50%\n\nRecipient Eligibility Criteria (for Part A and B Cohorts)\n\nInclusion\n\n* Signed informed consent document and authorization to use and disclose protected health information\n* Heart transplant candidate\n* Age ≥ 18 years old\n\nExclusion\n\n• Participant in any other interventional clinical or investigational trials\u002Fprograms that may confound the outcomes of this trial","ALL","18 Years",{"count":189,"type":190},655,"ESTIMATED","INTERVENTIONAL",[193],"NA","This trial is designed to evaluate the safety and effectiveness of the novel OCS Solution and OCS Functional Enhancer (OFE) to support FDA approval in both DBD and DCD heart transplantation. In addition, this trial will evaluate the performance of the novel OCS Solution and OFE compared to Static Cold Storage (SCS) in DBD heart transplantation to potentially demonstrate superiority.",[196],"Heart Transplant","2026-01-08",{"date":199,"type":200},"2026-01-12","ACTUAL",{"date":202,"type":190},"2026-01",{"date":204,"type":190},"2027-07-30",{"name":5,"class":6},8]